Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

DARK SECRETS: 3 | Rare Historical Photos

Australia backs cheaper medicines in face of US levies

The government says it won't back down or negotiate the pharmaceutical benefits scheme despite pressure from the Trump administration following new tariffs.

AAP

Trump threatens 100% tariff on drug makers that don’t strike deals to lower US prices

New tax will hit branded drugs and active ingredients while exempting generics for at least one year

The Guardian - US

Trump administration announces new tariffs on drugmakers

The administration will impose 100% tariffs on patented pharmaceuticals to force deals for lower drug prices.

Axios

From analysis to the latest developments in health,
read the most diverse news in one place.

Texas will launch its own clinical trials into ibogaine psychedelic after failing to find a drug company to help

The state’s effort will get a boost from the federal government thanks to a new executive order from President Donald Trump.

The Texas Tribune

Eli Lilly to Acquire Centessa Pharmaceuticals for Up to $7.8B in Sleep Drug Mega-Deal, CNTA Stock Soaring 45%

Shares of Centessa Pharmaceuticals plc skyrocketed more than 44% Tuesday after the clinical-stage biotech announced it would be acquired by pharmaceutical giant Eli Lilly and Co. in a deal valued at up to $7.8 billion, giving Lilly a promising pipeline of experimental treatments for sleep-wake disorders.

International Business Times

Pfizer Stock Edges Higher as Oncology Wins and Pipeline Bets Fuel Optimism Amid Flat 2026 Outlook

Pfizer Inc. shares ticked up modestly Tuesday as investors weighed fresh positive oncology data against the pharmaceutical giant's flat revenue guidance for 2026 and ongoing pressures from declining COVID-19 product sales.

International Business Times

From Rainforest Discovery to FDA Pipeline: Immune Modulation Advances a 30-Year Scientific Journey Toward Parkinson's Innovation

Immune Modulation, Inc., a California-based biotech company founded in 1995, is translating a plant-derived compound into a drug candidate now being prepared for regulatory pathways in Parkinson's disease.

International Business Times

Read news from The Economist, FT, and more,
with one subscription

Mounjaro maker wants NHS drug price rises in return for more investment in UK

US firm Eli Lilly, which is also pushing for end to rebate scheme, optimistic about talks with ministers

The Guardian - UK

Sali Hughes on beauty: finally, a dry skin remedy with a touch of elegance

Buying lard-like tubs of boring moisturiser is not your only option – fine and effective derma body lotions are now available

The Guardian - UK

Belgian drugmaker UCB to invest $2B in suburban Atlanta plant, adding 330 jobs

Belgian pharmaceutical maker UCB says it will build a $2 billion drug manufacturing plant near Atlanta

The Independent UK

Five Plead Guilty in $14.6M Fraud Diverting Funds Intended for Child Nutrition Funds

Five defendants plead guilty in the $14.6M Feeding Our Future fraud, exposing one of the largest pandemic scams targeting child nutrition funds.

International Business Times UK

Phizzle: Reframing Pharma Manufacturing Through Digitized Workflows to Strengthen Data Integrity and Operational Efficiency

Healthcare costs have surpassed $5 trillion in the United States and are increasing at approximately 8% annually, reinforcing the need for more streamlined and reliable systems that can support both compliance and performance.

International Business Times

FDA Recalls 90,000 Children's Ibuprofen Bottles Nationwide After Consumers Report Black Particles, Gel Mass

FDA Class II recall: Nearly 90,000 bottles of children's ibuprofen by Strides Pharma contaminated with black particles. Check lot numbers 7261973A and 7261974A to ensure safety. Learn about potential health risks and next steps.

International Business Times UK

AIM ImmunoTech Stock Today: AIM Surges 44% on Massive Volume After Patent Approval and Cancer Trial Progress

Shares of AIM ImmunoTech Inc. (NYSE American: AIM) rocketed higher Wednesday, closing at $1.02, up 31 cents or 43.66%, on extraordinarily heavy trading volume exceeding 183 million shares as investors reacted to a key patent milestone and ongoing clinical advancements in its lead drug Ampligen for pancreatic cancer.

International Business Times

Get all your
news in one place.

100's of premium titles.
One news app.

International Business Times

Your Mounjaro Knockoff Could Kill You

Boston Medical Group last year warned that purchasing Ozempic and other weight-loss drugs from unauthorized sellers is risky business, as their products can be fake or of poor quality. The FDA had already shut down more than 250 fake websites for selling counterfeit weight loss drugs or other medications.

International Business Times UK

Pharma Executives Sentenced to Decades for $92M Black‑Market HIV Drug Scheme

Pharma executives sentenced to decades in prison after a $92M black-market HIV drug scheme exposed illegal buybacks, unsafe resale practices, and fraud.

International Business Times UK

Ozempic Controversy Deepens as FDA Accuses Novo Nordisk of Failing to Report Patient Deaths, One Linked To Suicide

Novo Nordisk faces FDA scrutiny for failing to report Ozempic-linked deaths, highlighting systemic issues in safety reporting. Learn about the implications for patient safety and ongoing legal challenges.

The Guardian - UK

One of Britain’s last major chemical plants at risk as energy prices surge

If costs stay high for the next three months, US owner Peter Huntsman says he will close the site on Teesside

Get all your
news in one place.

100's of premium titles.
One news app.

Evening Standard

Illegal weight loss jabs being sold in London pubs and fish and chip shops, report claims

It is alleged beauticians and personal trainers are exploiting soaring interest in weight loss jabs

The Independent UK

Feds warn Ozempic and Wegovy maker over failure to report side-effects from weight-loss drugs

Officials wrote that Novo Nordisk had failed to failed to report ‘serious and unexpected’ adverse drug experiences

The Guardian - UK

Pipeline of new drugs to fight superbugs is ‘worryingly thin’, experts warn

UK’s GSK is leading the way in research but AstraZeneca is not involved in the area, report finds

The Independent UK

Novo Nordisk drops lawsuit over weight loss medications, enters collaboration with online pharmacy

The news sent shares of Hims & Hers Health Inc. soaring by more than 40% in Monday morning trading

Evening Standard

Former GlaxoSmithKline HQ in west London to be transformed into 1,500 new homes

Ambitious plans to redevelop the former headquarters of GlaxoSmithKline in Brentford have been given the green light

The Guardian - US

Trump administration’s embattled FDA vaccine chief departing for the second time

Vinay Prasad to leave in April after decisions involving vaccine reviews and specialty drugs for rare diseases

The Times of India

Navjot, Attarvir, Balwinder and Manpreet Singh charged after $2.3 million in suspected fentanyl seized in Brampton

Police have charged four men and seized more than $2.3 million worth of suspected fentanyl as part of a major drug trafficking investigation that stretched from the Greater Toronto Area to Alberta.

1 2 3 4 5

People

Katharine Neill Harris

12 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.